Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensified Dosing of Cellcept in Kidney Transplantation Trial
NCT00943228Phase 4Completed
- Sponsor
- Nova Scotia Health
- Start
- Feb 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mycophenolate mofetil in acute renal transplant rejection, sponsored by Nova Scotia Health. Primary endpoint: Mycophenolic Acid Area Under the Curve at 14 days. Started Feb 2010; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
acute renal transplant rejection
Beyond the preview
Go deeper on NCT00943228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00943228.